6 Colo. Code Regs. § 1009-7-A
Disease/Event | Type | Time | Reporter |
Adverse drug reaction or overdose caused by taking a prescription drug, over-the-counter medication or remedy, controlled substance (legally or illegally obtained) that results in treatment in an emergency department, hospitalization, or death | 120 days1 | P* | |
Autism Spectrum Disorders (ASD) (Age less than or equal to ten years) (Including Autistic Disorder, Asperger's Syndrome, and Pervasive Developmental Disorder-Not Otherwise Specified) | 30 days | P** | |
Chromosomal abnormalities and neural tube defects diagnosed by prenatal testing or by genetic testing in Colorado residents through the third birthday | 90 days | P | |
Fetal Alcohol Syndrome (Age &<= 10 years) | 30 days | P | |
Head injuries requiring admission to hospitals or resulting in death | 120 days1 | L & P* | |
Lead Level, elevated | |||
Blood lead level &>= 5 µg/dL AND age &<= 18 years | 7 days | L & P*** | |
Blood lead level &>= 5 µg/dL if age &>18 years | 30 days | L & P*** | |
Blood lead level <5 µg/dL AND age &<= 18 years | 30 days | L & P*** | |
Mercury Level, elevated | |||
Blood mercury >0.5 µg/dL | 30 days | L | |
Urine mercury >20 µg/L | 30 days | L | |
Muscular Dystrophies | 120 days1 | P | |
Spinal Cord Injuries | 120 days1 | L & P* | |
Birth defects, developmental disabilities, and medical risk factors for developmental delay in Colorado residents diagnosed prenatally, at birth, or through the third birthday; with the exception of muscular dystrophies, which shall be reported without age limit2 | |||
Major congenital malformations, deformations and chromosomal abnormalities | 120 days1 | L & P* | |
Congenital (perinatal) infections, including: Congenital syphilis Congenital rubella Cytomegalovirus Toxoplasmosis/herpes viral/herpes simplex Neonatal viral hepatitis | 120 days1 | L & P* | |
Sensory impairments, including: Hearing loss Blindness and low vision | 120 days1 | L & P* | |
Other disabilities, including: Specific delays in development Change to Intellectual Disability Infantile cerebral palsy Autism spectrum disorders (ASD) | 120 days1 | L & P* | |
Newborn genetic/endocrine/metabolic and newborn immunodeficiencies diseases | 120 days1 | L & P* | |
Infections, including: Encephalitis Meningitis | 120 days1 | L & P* | |
Injuries, including: Traumatic brain injuries Spinal cord injuries | 120 days1 | L & P* | |
Other disabilities and medical conditions related to development, including: Convulsions/seizures Specific delays in development Intellectual disabilities Infantile cerebral palsy Autism spectrum disorders (ASD) Drug withdrawal syndrome in | 120 days1 | L & P* | |
the newborn Failure to thrive Infantile spasms Muscular dystrophies Noxious influences affecting fetus (includes Fetal Alcohol Syndrome) Werdnig Hoffman disease Amniotic bands Perinatal Intracranial hemorrhage Slow fetal growth and fetal malnutrition |
1 Reporting time is 120 days unless it is to be reported sooner under a different statutory or regulatory authority.
2 Listed conditions relate directly to the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM)
Reporter: The party responsible for reporting is indicated by one of the following:
L = Laboratory (whether or not associated with a hospital; by out-of-state laboratories that maintain an office or collection facility in Colorado; and by in-state laboratories which send specimens to an out-of-state laboratory referral laboratory).
P = Health care providers, coroners, laboratories, hospitals.
* Reporting requirement is fulfilled through Department access to administrative data sets including but not limited to hospitalization and emergency discharge data and vital records data, unless notified by the Department that additional data are necessary or otherwise required by statute or regulation.
** Condition reportable only among residents of seven-county Denver Metropolitan Area
(Adams, Arapahoe, Boulder, Broomfield, Denver, Douglas and Jefferson Counties).
*** Laboratory as specified above or by the physician, healthcare provider, or clinic when blood lead specimens are analyzed in an office or outpatient setting (i.e., using LeadCare® II instrument).
6 CCR 1009-7-A